Taysha Gene Therapies Inc. (TSHA)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 70
+0.01
+0.1757%
$
1.82B Market Cap
- P/E Ratio
- Div Yield
1.76M Volume
-0.41 Eps
$ 5.69
Previous Close 
Want to track TSHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?
Taysha Gene Therapies (NASDAQ: TSHA ) stock is taking a beating on Wednesday after the gene therapy company announced a proposed public offering for its shares. Taysha Gene Therapies says that it intends to offer up to $75 million worth of TSHA stock in this offering.
Investorplace | 2 years ago
What's Going On With Taysha Gene Therapies Stock Tuesday?
Tuesday, Taysha Gene Therapies Inc TSHA released longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in Rett syndrome.
Benzinga | 2 years ago
